News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novotech Pty Ltd. To Present Benefits Of Outsourcing Clinical Trials To Australia; CEO Invited To Speak At Inaugural Sachs Bloomberg CRO Partnering Forum, Boston


10/19/2005 5:13:00 PM

BOSTON--(BUSINESS WIRE)--March 14, 2005--Novotech, Australia's leading contract research organization (CRO), CEO Alek Safarian has been invited to present Australia's outstanding clinical trials capabilities at the inaugural Sachs Bloomberg CRO Partnering Forum in Boston (March 15, 2005). In the past three years, Novotech has worked with more than 15 U.S.-based pharmaceutical and biotech companies, as well as many major European pharmas.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES